PanOptica
Mt. Arlington, US · Founded 2009 · Massachusetts corporation · 3 known investors
Biotech
Founders & leadership
PC
Paul ChaneyNamed on SEC filing
KS
Kevin StarrNamed on SEC filing
LG
Lutz GiebelNamed on SEC filing
CG
Colin GoddardNamed on SEC filing
Board
AC
DG
David GuyerBoard director
BP
Investors · 3
Reported raises · per SEC filings
Form D private placements$57.3M disclosed across 2 rounds · 2010–2014
▶$40.7MraisedApr 2019 · 6 investors · BiotechnologyRule 506(b)
▶$40.7MraisedApr 2019 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Abbie CelnikerDirector
- David GuyerDirector
- Paul ChaneyExecutive Officer, Director
- Bruce PeacockDirector
- Offering amount
- $47.3M
- Amount sold
- $40.7M
- First sale
- Apr 2014
- Incorporated
- Corporation, Massachusetts
- Federal exemptions
- 06b
▶$16.6MraisedMar 2012 · 5 investors · BiotechnologyRule 506(b)
▶$16.6MraisedMar 2012 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin StarrDirector
- David GuyerDirector
- Lutz GiebelDirector
- Paul ChaneyExecutive Officer, Director
- Colin GoddardDirector
- Offering amount
- $36.1M
- Amount sold
- $16.6M
- First sale
- Dec 2010
- Incorporated
- Corporation, Delaware, 2009
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are PanOptica's investors?
- PanOptica's investors include Astellas Venture Management LLC, Agent Capital, Third Rock Ventures.
- How much funding has PanOptica raised?
- PanOptica has disclosed $57.3M raised across 2 rounds.
- Where is PanOptica headquartered?
- PanOptica is headquartered in Mt. Arlington, US.
